OCULUS INNOVATIVE SCIENCES I's ticker is OCLSW and the CUSIP is 67575P116. A total of 5 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,312,000 | +116.5% | 532,726 | +100.0% | 0.25% | +21.6% |
| Q2 2016 | $1,068,000 | +111.5% | 266,363 | -67.3% | 0.20% | +175.7% |
| Q1 2016 | $505,000 | +33.6% | 815,229 | +147.8% | 0.07% | -39.3% |
| Q4 2015 | $378,000 | -10.8% | 328,994 | 0.0% | 0.12% | -0.8% |
| Q3 2015 | $424,000 | +186.5% | 328,994 | 0.0% | 0.12% | +78.3% |
| Q2 2015 | $148,000 | – | 328,994 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 815,229 | $505,000 | 0.07% |
| Ionic Capital Management LLC | 232,344 | $67,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 12,000 | $3,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,029 | $3,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 22,190 | $6,000 | 0.00% |